Omnicare Inc

Omnicare — Q3 2010 Earnings Presentation

22 slides from Omnicare's earnings presentation, Nov 2, 2010

  1. Slide 1: November 2, 2010

    November 2, 2010

  2. Slide 2: Forward-Looking Statements

    Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned that such statements are only predictions and that actual events or results may differ materially. These forward-looking statements spea

  3. Slide 3: Omnicare Today: A Senior Care Pharmacy Services Company

    Industry leader 47 states, District of Columbia and Canada 120 million prescriptions dispensed per year Nation’s largest provider of hospice pharmacy Global contract research organization Omnicare Today… A Senior Care Pharmacy Services Company – –

  4. Slide 4: Omnicare Growth Drivers

    Demographic trends Pharmaceutical market trends Strategic objectives Omnicare Growth Drivers

  5. Slide 5: Aging Population Shaping Healthcare

    Life expectancy continues to lengthen Significant population mix shift towards seniors Source: U.S. Census Bureau Demographic Trends Aging Population Shaping Healthcare

  6. Slide 6: Pharmaceutical Market Trends

    Branded drugs Major market shift to generic drugs Development and use of biologics increasing Pharmaceutical Market Trends

  7. Slide 7: Increasing Utilization of Generics

    (1) Generic prescriptions dispensed as a percent of total scripts Brand to Generic Drugs Increasing Utilization of Generics

  8. Slide 8: Major Shift to Generic Drugs: Benefits

    Buy-side margin Favorable impact on working capital Top 100 generic drug analysis Major Shift to Generic Drugs Benefits

  9. Slide 9: Generic Drugs Long-Term Trends

    Top 100 generics based on revenue 94% of these older generics providing positive contribution relative to brand Generic Drugs Long-Term Trends

  10. Slide 10: 2010-2013 Potential Patent Expirations

    (1) All generic launches are subject to change due to litigation or pediatric exclusivity. (2) Drugs already launched shown in gray and italics 2010 2011 2012 2013 Arimidex Fazaclo Actos Aciphex Cozaar Femara Diovan Asacol Effexor ER Gabitril Exelon Patch Avodart Exelon Caps Levaquin Geodon Cymbalta

  11. Slide 11: Specialty Pharmaceuticals: A Growth Industry

    (1) Source: EvaluatePharma Pharmaceutical Market Share (1) by Drug Type • Mail order • Oncology and multiple sclerosis Outsourced services for biotechnology firms Omnicare’s institutional pharmacies Conventional Drugs, 72% Other, 19% Omnicare’s Positioning Within Specialty Pharmaceuticals… Specialty

  12. Slide 12: Strategic Objectives

    Productivity improvements Cost-reduction initiatives Customer growth Skilled nursing facilities (SNFs) Assisted living facilities (ALFs) Other institutional settings Specialty pharmacy Strategic Objectives – – – –

  13. Slide 13: Transitioning to an Operations-Driven Company

    Cultural transformation Instill collaborative environment, encourage employee innovation Revamp budgeting process Reinforce a commitment to compliance Reallocation of resources Align employee interests Reshape the organization, bringing it closer to the customer Improve accountability with regional

  14. Slide 14: Cost-Reduction Initiatives

    Drug purchasing Leveraging brand and generic drug purchasing power Strategic sourcing Capitalizing on scale with non-drug purchases Operating initiatives Hub-and-spoke network, new technologies, best practices (1) P&L savings realized for trailing four quarters through the third quarter of 2010. Pro

  15. Slide 15: Initiatives Focused on Organic Growth

    Enhance the customer experience Align customer retention with incentive programs Proactive vs. reactive approach to customer service Reposition leading technology offering Improve selling effectiveness Re-engage sales consulting group Improve coordination of selling process Revamped incentive progra

  16. Slide 16: Broadening Markets

    Assisted living market CCRCs, independent living Mental health market, rural hospitals, prisons Customer Growth Broadening Markets

  17. Slide 17: Focus on Assisted Living Opportunity

    Assisted Living: Three-Pronged Growth Opportunity Customer Growth Focus on Assisted Living Opportunity

  18. Slide 18: Specialty Pharmacy: Growth Outside Institutional Setting

    Omnicare specialty pharmacy growth rates have outpaced robust industry growth rates…but opportunities exist to further accelerate growth through: Addition of new leadership Tighter coordination of efforts Penetrate additional disease states (for ACS) Primary disease states currently multiple scleros

  19. Slide 19: Third Quarter 2010 Highlights

    Scripts dispensed increased 1.3% sequentially – One additional calendar day in 3Q 2010 as compared with 2Q 2010 – Number of beds served up sequentially – Utilization stable – Census was lower, although rate of decline improved from 2Q 2010 Qtr. ending number of beds served (1) up 32,000 sequentially

  20. Slide 20: Capital Returned to Shareholders

    (1) Cumulative % Returned = (YTD Dividends Paid + YTD Share Repurchases) / 12/31/09 Market Capitalization of $2,908.4 million. Capital Returned to Shareholders

  21. Slide 21: Omnicare's Fundamental Value Drivers

    Favorable industry dynamics Industry leading position Scale business Solid financial position Substantial cash flow generator Enhancing efficiency of operations Opportunities to leverage core business Omnicare’s Fundamental Value Drivers

  22. Slide 22: November 2, 2010

    November 2, 2010

Omnicare — Q3 2010 Earnings Presentation on 6ix